Compound class:
Synthetic organic
Comment: TXA709 is an orally bioavailable prodrug of TXA707 (PubChem: 90135655), a benzamide antibacterial compound that inhibits the essential and conserved prokaryotic cell division protein FtsZ [3]. TXA709 is under clinical development, as a combination therapy with synergistic drug partners, for infections caused by methicillin-resistant Staphylococcus aureus (MRSA) [1-2].
|
|
Classification | |
Compound class | Synthetic organic |
IUPAC Name |
N-[2,6-difluoro-3-[[6-(trifluoromethyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]methoxy]benzoyl]-1-methylpiperidine-4-carboxamide |
Database Links | |
Specialist databases | |
Antibiotic DB | TXA-709, active metabolite TXA-707 |
Other databases | |
CAS Registry No. | 1609670-80-5 (source: Scifinder) |
ChEMBL Ligand | CHEMBL3908543 |
GtoPdb PubChem SID | 491299942 |
PubChem CID | 75203933 |
Search Google for chemical match using the InChIKey | LOTYKTRNFDRNAY-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | LOTYKTRNFDRNAY |
UniChem Compound Search for chemical match using the InChIKey | LOTYKTRNFDRNAY-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | LOTYKTRNFDRNAY-UHFFFAOYSA-N |